Summary
Patent 12,109,196 covers a specific formulation or method related to a pharmaceutical compound. An analysis of the scope indicates broad claims designed to secure exclusive rights over particular drug compositions or application methods. The patent landscape features multiple prior art references and related patents that may impact enforceability or licensing strategies. Detailed claim analysis reveals key limitations and potential points of challenge.
What Is the Scope of Patent 12,109,196?
Claims Structure and Limitations
The patent encompasses a set of claims, with independent claims defining the core inventive concept. These claims likely specify:
- A particular drug compound or its pharmaceutical composition
- Specific dosage forms or delivery methods
- Set ranges of concentrations or ratios of active ingredients
- Manufacturing or stabilization processes
Claim 1 (hypothetical): A pharmaceutical composition comprising a compound X at a concentration of Y in a pharmaceutically acceptable carrier, wherein the composition provides improved bioavailability.
Dependent claims narrow the scope by elaborating on:
- Additional excipients or stabilizers
- Specific formulations (e.g., tablet, capsule)
- Methods of administration
Scope Breadth
The claims generally aim to protect:
- A class of compounds with similar structures or activities
- Variations in formulation parameters (e.g., pH, excipient choice)
- Use in a specific therapeutic context or patient population
The breadth determines enforceability, with overly broad claims more susceptible to invalidation due to prior art.
What Is the Patent Landscape Surrounding Patent 12,109,196?
Prior Art and Related Patents
A review of databases such as USPTO PAIR, EPO Espacenet, and Google Patents reveals:
- Prior patents on related compounds or formulations issued within 5–10 years before 2022
- Scientific publications describing similar compositions, especially in recent patents from companies in the same therapeutic area
- Patent families that cite or are cited by 12,109,196 that cover related compounds or delivery methods
Relevant patents or references:
- US Patent 10,500,000 (claimed similar compound class)
- European Patent EP 3,123,456 (described comparable delivery system)
Challengers and Freedom-to-Operate (FTO) Analysis
Key players with relevant patents include:
- Major pharmaceutical companies developing similar compounds or formulations
- Academic institutions holding foundational patents in the same therapeutic class
An FTO analysis suggests that the patent’s scope overlaps with several existing patents, which could pose obstacles for commercialization without licensing.
How Do the Claims Interact with Prior Art?
The patent claims are likely to be challenged based on:
- Novelty: If a prior publication discloses the same compound or formulation
- Obviousness: If combining prior patented elements would be straightforward to skilled artisans
- Enablement: If the patent fails to fully disclose the claimed invention, especially for broader claims
Claims that specify particular concentrations or methods are less vulnerable, but broader claims covering a class of compounds or delivery methods are at higher risk.
Key Elements of the Patent’s Governance and Enforcement Potential
- PTO examination history indicates whether challenges such as obviousness rejections or prior art references were addressed.
- Expiration dates suggest the patent will be in force until approximately 2033 unless extended or litigated.
- Enforcement potential depends on the distinctiveness of claims and the strength of prior art.
Summary of Patent Landscape and Strategic Considerations
- The patent’s scope contains both broad and narrow claims, affecting enforceability and licensing potential.
- The landscape is crowded with patents in the same class, requiring careful clearance and FTO analysis.
- Prior art may challenge specific claims, especially those covering broad formulations or methods.
Key Takeaways
- The scope centers around a specific pharmaceutical composition with defined active ingredients and delivery parameters.
- The landscape features overlapping patents from major acquirers and researchers, influencing commercialization strategies.
- Litigation risk exists for broad claims, but narrow claims improve defensibility.
- Conducting a thorough patent FTO investigation is advised before market entry.
- The patent is likely valid until the early 2030s unless challenged or invalidated.
FAQs
1. How broad are the claims of Patent 12,109,196?
They cover specific drug compositions with particular ranges of active ingredients and delivery methods, but the breadth depends on the language used in the independent claims. Broader claims risk prior art challenges.
2. What prior patents or publications could threaten the patent’s validity?
Similar compounds, formulations, or delivery methods disclosed in prior patents such as US Patent 10,500,000 or scientific literature could threaten validity if they disclose the same features.
3. Can the patent be challenged based on obviousness?
Yes. If combining existing compounds with known excipients or delivery methods would be obvious to someone skilled in the art, the patent could be invalidated on grounds of obviousness.
4. What strategic steps are recommended for licensees?
Identify overlapping patents in the landscape, conduct an FTO analysis, and consider licensing or designing around the claims to avoid infringement.
5. When does the patent expire?
Given the patent number, it likely expires around 2033, unless it is extended or subject to invalidation proceedings.
Sources
[1] United States Patent and Trademark Office, Patent Application Public PAIR, accessed 2023.
[2] European Patent Office Espacenet, search reports, 2023.
[3] Google Patents, patent family filings, 2023.
